Amphastar Pharmaceuticals AMPH EV / EBITDA
EV / EBITDA at other companies
Other financials
Where this comes from
Calculated from Amphastar Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's ev / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's EV / EBITDA?
- Amphastar Pharmaceuticals (AMPH) reported EV / EBITDA of 8.1× in Q1 2026.
- How has Amphastar Pharmaceuticals's EV / EBITDA changed year-over-year?
- Amphastar Pharmaceuticals's EV / EBITDA increased by 8.1% year-over-year, from 7.5× to 8.1×.
- What is the long-term trend for Amphastar Pharmaceuticals's EV / EBITDA?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's EV / EBITDA has grown at a -21.3% compound annual growth rate (CAGR), from 28.9× to 8.7×.
- What does EV / EBITDA mean?
- Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.